Patents Assigned to SmithKline Beecham Farmaceutica S.p.A.
  • Quinoline derivatives
    Patent number: 7482458
    Abstract: NK3 receptor antagonists of formula (I): are useful in treating inter alia pulmonary disorders, CNS disorders and neurodegenerative disorders.
    Type: Grant
    Filed: March 21, 2006
    Date of Patent: January 27, 2009
    Assignee: SmithKline Beecham Farmaceutica S.p.A.
    Inventors: Carlo Farina, Giuseppe Arnaldo Maria Giardina, Mario Grugni, Luca Francesco Raveglia